Overall survival according to donor source in patients younger than 45 years who received TBI regimens. The 4-year overall survival rates in patients undergoing auto-SCT and allo-SCT were 71% (95%CI: 52 to 84) and 66% (95%CI: 62 to 70), respectively (p=0.510).